Clicky

Grifols, S.A.(GRFS)

Description: Grifols, S.A., a specialty biopharmaceutical company, develops, manufactures, and distributes a range of plasma derivative products primarily in the European Union, Spain, the United States, and Canada. It specializes in providing infusion solutions, nutrition products, medical devices, and diagnostic instrumentation and reagents for use in hospitals and clinics. The company operates in four divisions: Bioscience, Diagnostic, Hospital, and Raw Materials and Others. The Bioscience division manufactures and sells plasma derivatives for therapeutic use, including the reception, analysis, quarantine, classification, fractionation, and purification of plasma; and sells and distributes end products. This division offers plasma products, such as IVIG, Factor VIII, A1PI, and albumin; and intramuscular immunoglobulins, ATIII, Factor IX, and plasma thromboplastin components. The Diagnostic division focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products, such as analytical instruments and reagents for diagnostics, as well as blood bank products. This division serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital division manufactures and installs products used by and in hospitals comprising parenteral solutions, and enteral and parenteral nutritional fluids. The Raw Materials and Others division engages in the sale of intermediate pastes and plasma to third parties. The company's products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and a range of other medical conditions. The company was formerly known as Probitas Pharma, S.A. and changed its name to Grifols, S.A. in 2005. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.


Keywords: Medicine Biopharmaceutical Infectious Diseases Clinic Healthcare Providers Antibody Ibex 35 Nutrition Products Hematology Derivative Products In Vitro Hemophilia In Vitro Diagnostics Transfusion Medicine Diagnostics Products Blood Plasma Blood Bank Infusion Solutions Analytical Instruments Grifols Plasma Products Parenteral Nutrition Hospital Immunohematology Services In Vitro Diagnostics Products Parenteral Solutions Bank Products Blood Donation

Home Page: www.grifols.com

GRFS Technical Analysis

Avinguda de la Generalitat, 152
Barcelona, 08174
Spain
Phone: 34 93 571 02 21


Officers

Name Title
Mr. Steven Francis Mayer J.D. Exec. Chairman
Mr. Raimon Grifols Roura Co-CEO & Exec. Director
Mr. Víctor Grifols Deu Co-CEO & Exec. Director
Mr. Alfredo Arroyo Guerra CFO & VP
Mrs. Eva Bastida Tubau Corp. VP and Director of Scientific & Medical Affairs
Ms. Nuria Pascual Lapeña VP of Corp. Treasury, Risk Management Investor Relation & Sustainability Officer
Mr. David Ian Bell Gen. Counsel & Chief Corp. Devel. Officer
Mr. Mateo Florencio Borrás Humbert Corp. VP & Chief HR Officer
Ms. Maria Teresa-Rioné Llano Chief Communications Officer
Ms. Montserrat Gaja Llamas Chief HR Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 13.2802
Trailing PE: 88.5
Price-to-Book MRQ: 0.7986
Price-to-Sales TTM: 1.2683
IPO Date: 2006-05-17
Fiscal Year End: December
Full Time Employees: 27584
Back to stocks